Accelerate Diagnostics Analyst Ratings
Craig-Hallum Maintains Hold on Accelerate Diagnostics, Lowers Price Target to $1
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Stockholders Beware: Accelerate Diagnostics' Surge in Authorized Shares Signals Potential Dilution Risk
Analysts Conflicted on These Healthcare Names: Schrodinger (SDGR), Accelerate Diagnostics (AXDX) and Staar Surgical (STAA)
Craig-Hallum Sticks to Their Hold Rating for Accelerate Diagnostics (AXDX)
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), SurModics (SRDX) and Accelerate Diagnostics (AXDX)
Craig Hallum Cuts Accelerate Diagnostics Price Target to $0.60 From $2, Maintains Hold Rating
No Data
No Data